Summary
The European Society of Cardiology will be participating in the Scientific Sessions of the American College of Cardiology with one Joint Scientific Session with the ESC and one with the European Heart Journal.
Sunday 3 April 2022
ESC/ACC Joint Session - Seismic Changes in Novel Therapies for CVD Management and Risk Reduction: International Perspectives
Session Description: This session will include perspectives from international thought leaders on newer therapies and devices and issues in implementation in clinical practice: availability and access, costs, ethnic/racial variations in response/side effects of therapies/devices, healthcare disparities, impact on international clinical practice guidelines. Experts will help to answer the questions “Where are we?” and “Are we there yet?”.
Moderators
Stephan Achenbach (Germany), Dipti Itchhaporia, (USA)
| 2:00 PM - 3:15 PM U.S. Eastern Daylight Time (GMT -04:00) Room 151A |
||
|---|---|---|
| 15 minutes |
PCSK9 is the Target: What’s the Best Therapy? This presentation will focus on the role of monoclonal antibodies and the newer siRNA therapy, Inclisiran (recently approved in Europe), in ASCVD risk reduction and management of FH. |
Ulf Landmesser, Germany |
| 15 minutes |
Monitoring and Me, Myself, and I: Wearables and Remote Monitoring Devices in Clinical Practice. This presentation will consider wearable devices/remote monitoring and their role in the outpatient setting. |
Edward Fry, USA |
| 15 minutes |
A Misfolded Mess: Contemporary Approaches to ATTR-Cardiomyopathy This presentation will consider diagnosis and management of ATTR-CM and the role of tafamidis/tafamidis meglumine in management of disease. |
Perry Elliott, United Kingdom |
| 15 minutes |
The Road Less Traveled: Diabetes Therapies en route to Heart Failure Superstars In this presentation, speaker will consider the role of the SGLT2i/GLP1-RA in heart failure (HFrEF and HFpEF) in patients without diabetes. |
Mary Norine Walsh, USA |
| 15 minutes | Panel Discussion / Q&A | All speakers |
Monday 4 April 2022
The European Heart Journal's Year in Cardiovascular Medicine: Joint Symposium of the European Society of Cardiology and the American College of Cardiology II - at ACC.22.
Chairpersons
Filippo Crea (Italy), Dipti Itchhaporia (USA)
| 8:30 am - 9:45 am U.S. Eastern Daylight Time (GMT -04:00) Room 143A | ||
|---|---|---|
| 15 minutes | Heart Failure | Johann Bauersach, Germany |
| 15 minutes | Arrhythmias | DJ Lakkireddy, USA |
| 15 minutes | Ischemic Heart Disease | Rasha Al-Lamee, United Kingdom |
| 15 minutes | Dyslipidemia | Vera Bittner, USA |
| 15 minutes | Panel Discussion / Q&A | All speakers |
Connect with the ESC
Create your My ESC Account – your gateway to the ESC. It’s free and available in a few short clicks! Want regular updates on ESC science, tools and congresses and education?
About the European Society of Cardiology
The ESC is the world’s largest organisation of healthcare professionals dedicated to fighting heart disease. It helps more than 100,000 clinicians, scientists, nurses and allied professionals expand the boundaries of cardiovascular medicine.
The ESC publishes scientific journals, an array of textbooks and world renowned ESC Clinical Practice Guidelines. It provides continuing medical education through webinars and classroom courses, and hosts the summit of cardiovascular science each August - ESC Congress - which attracts more than 32,000 heart specialists.
Join our community of cardiologists from more than 150 countries - Become an ESC Professional Member.
Our mission: To reduce the burden of cardiovascular disease.